bmi for tirzepatide as Compared with Semaglutide the Treatment of Obesity Tirzepatide For Obesity: “Mounting” Evidence

Both drugs can cause stomach-related problems, but these side effects tend to occur more often in people taking tirzepatide

At the cellular level, GLP-1 receptor activation appears to reduce the production of pro-inflammatory cytokines such as tumor necrosis factor-alpha (TNF-), interleukin-6 (IL-6), and interleukin-1 beta (IL-1)

This combined method is a key part of tirzepatide treatment, where patients attend follow-up visits to stay informed about heart health and manage their weight

Clinicians should counsel patients to avoid them

How GLP-1 Medications Work at Lower Doses GLP-1 receptor agonists mimic a natural gut hormone called glucagon-like peptide-1